Versant Venture Capital VI, L.P.'s Net Worth
$293 Million
Who is Versant Venture Capital VI, L.P.?
Versant Venture Capital VI, L.P. has an estimated net worth of $293 Million. This is based on reported shares across multiple companies, which include Graphite Bio, Inc., Repare Therapeutics Inc., Monte Rosa Therapeutics, Inc., Century Therapeutics, Inc., Oyster Point Pharma, Inc., Akero Therapeutics, Inc., Aligos Therapeutics, Inc., Tempest Therapeutics, Inc., Pandion Therapeutics, Inc., Passage BIO, Inc., and Black Diamond Therapeutics, Inc..
SEC CIK
Versant Venture Capital VI, L.P.'s CIK is 0001687880
Past Insider Trading and Trends
2020 was Versant Venture Capital VI, L.P.'s most active year for acquiring shares with 77 total transactions. Versant Venture Capital VI, L.P.'s most active month to acquire stocks was the month of May. 2020 was Versant Venture Capital VI, L.P.'s most active year for disposing of shares, totalling 191 transactions. Versant Venture Capital VI, L.P.'s most active month to dispose stocks was the month of December. 2020 saw Versant Venture Capital VI, L.P. paying a total of $29,049,984.00 for 29,230,767 shares, this is the most they've acquired in one year. In 2019 Versant Venture Capital VI, L.P. cashed out on 16,894,884 shares for a total of $20,081,962.66, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
LENZ Therapeutics, Inc. (GRPH) Snapshot price: $2.915
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +245.21% | 598.2K |
—
|
—
| 842.16K |
Mar 21
| |||
Form 4
| +594.22% | 14.05M |
$17.00 |
—
| 16.42M |
Jun 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Repare Therapeutics Inc. (RPTX) Snapshot price: $7.8
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -22.54% | -1.45M |
$12.25 | -$9,188,775.00 | 4.98M |
Jun 3 - Jun 6
| |||
Form 4
| -39.68% | -152.07K |
—
|
—
| 231.21K |
Scheduled
|
Aug 5
| ||
Form 4
| -16.37% | -75.00K |
—
|
—
| 383.28K |
Jun 1
| |||
Form 4
| -9.99% | -240.75K |
—
|
—
| 2.17M |
Scheduled
|
May 5
| ||
Form 4
| -10.29% | -350.00K |
—
|
—
| 3.05M |
Scheduled
|
Feb 16
| ||
Form 4
| -9.36% | -600.00K |
—
|
—
| 5.81M |
Scheduled
|
Jan 29
| ||
Form 4
| -7.23% | -500.00K |
—
|
—
| 6.41M |
Scheduled
|
Jan 14
| ||
Form 4
| -10.12% | -325.00K |
—
|
—
| 2.88M |
Scheduled
|
Dec 15
| ||
Form 4
| +64.65% | 6.5M |
$20.00 | $5,000,000.00 | 16.54M |
Jun 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Monte Rosa Therapeutics, Inc. (GLUE) Snapshot price: $4.64
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +3,041.10% | 8.61M |
$19.00 |
—
| 8.9M |
Jun 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Century Therapeutics, Inc. (IPSC) Snapshot price: $4.55
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -7.40% | -914.80K |
$13.03 | -$7,166,610.00 | 11.45M |
Scheduled
|
Aug 9
| ||
Form 4
| -1.43% | -179.00K |
—
|
—
| 12.37M |
Jan 31
| |||
Form 4
| -2.87% | -371.00K |
—
|
—
| 12.55M |
Scheduled
|
Dec 23
| ||
Form 4
| +357.29% | 10.65M |
$20.00 |
—
| 13.63M |
Jun 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Oyster Point Pharma, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -3.66M |
—
|
—
|
0
|
Jan 3
| |||
Form 4
| -32.57% | -201.47K |
—
|
—
| 417.07K |
Scheduled
|
Jan 5
| ||
Form 4
| -24.57% | -201.47K |
—
|
—
| 618.55K |
Scheduled
|
Dec 21
| ||
Form 4
| -22.59% | -550.00K |
$14.86 | -$8,160,736.41 | 1.88M |
Scheduled
|
Oct 18
| ||
Form 4
| -19.05% | -322.36K |
—
|
—
| 1.37M |
May 12
| |||
Form 4
| -16.00% | -322.36K |
—
|
—
| 1.69M |
Mar 26
| |||
Form 4
| -12.69% | -325.00K |
—
|
—
| 2.24M |
Scheduled
|
Feb 17
| ||
Form 4
| +1,630.55% | 5.26M |
$16.00 |
—
| 5.58M |
Nov 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |